Healthcare -
Biotechnology - NASDAQ - US
$ 32.65
0.276 %
$ 3.64 B
Market Cap
-34.73
P/E
VKTX - CHANGE IN WORKING CAPITAL
Change in Working Capital VKTX - Viking Therapeutics, Inc.
3.55 M
LAST VALUE
79.23%
2 YEAR CAGR
33.94%
5 YEAR CAGR
63.85%
10 YEAR CAGR